Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 308
Selected: 0
NCT IDTitle
NCT01551459A Phase II Study of Sunitinib Versus Dacarbazine in the Treatment of Patients With Metastatic Uveal Melanoma
NCT00755885Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer
NCT01752569A Study of Selumetinib in Patients With Kaposi's Sarcoma
NCT04870580[18F] FDOPA PET Imaging in Glioma: Feasibility Study for PET Guided Brain Biopsy
NCT03687645Hyperpolarised 13C-Pyruvate MRI Study
NCT03415854Paclitaxel Protein Bound Plus Cisplatin Plus Gemcitabine and Paricalcitol for Pancreatic Adenocarcinoma (NABPLAGEMD)
NCT05541601Prospective Cohort for Early Detection of Liver Cancer
NCT00829205Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment
NCT01602588A Randomised Trial Investigating the Additional Benefit of Hydroxychloroquine(HCQ)to Short Course Radiotherapy (SCRT) in Patients Aged 70 Years and Older With High Grade Gliomas (HGG)
NCT06320067A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
NCT05770102DETERMINE Trial Treatment Arm 02: Atezolizumab in Adult, Paediatric and Teenage/Young Adult Patients With Cancers With High Tumour Mutational Burden (TMB) or Microsatellite Instability-high (MSI-high) or Proven Constitutional Mismatch Repair Deficiency (CMMRD) Disposition
NCT00977210Safety Study of OXi4503 (a Vascular Disrupting Agent) Given by 3 x Weekly Intravenous Infusions to Patients With Advanced Solid Tumors
NCT07432932Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients
NCT01147029GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
NCT02960620Therasphere for Unresectable Primary or Secondary Liver Neoplasia
NCT00674557Exemestane With or Without ATN-224 in Treating Postmenopausal Women With Recurrent or Advanced Breast Cancer
NCT04478929Early Detection of Barrett's Esophagus Through Deep Image Retrieval
NCT00004209Combination Chemotherapy in Treating Patients With Stage IIIB or Stage IV Non-small Cell Lung Cancer
NCT02546921Phase I Study of MOv18 IgE
NCT01719835CHOP vs GEM-P in 1st Line Treatment of T-cell Lymphoma, Multicentre Phase II Study
NCT01668550A Phase I Study of AZD0424 Alone and in Combination in Advanced Solid Tumours
NCT03916510Chemoradiation With Enadenotucirev as a Radiosensitiser in Locally Advanced Rectal Cancer
NCT00993655Intraperitoneal vs Intravenous Chemotherapy Following Neoadjuvant Chemotherapy in Ovarian Cancer
NCT02688257Assessing Treatment Response in Breast Cancer With Functional Imaging
NCT00275132Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
NCT01791985AZD4547 & Anastrozole or Letrozole (NSAIs) in ER+ Breast Cancer Patients Who Have Progressed on NSAIs (RADICAL)
NCT00720447Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
NCT01263171Oxaliplatin, Leucovorin, and Fluorouracil Before and After Radiation Therapy and Surgery in Treating Patients With Rectal Cancer That Can Be Removed by Surgery
NCT02330926Multimodal Intervention for Cachexia in Advanced Cancer Patients Undergoing Chemotherapy
NCT04257461A Trial to Evaluate the Potential Benefit of Adjuvant Chemotherapy for Small Bowel Adenocarcinoma
NCT07002320Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer
NCT04118192NOSTRA-Feasibility Study: A Study Looking at Ultrasound Guided Biopsies for Breast Cancer
NCT04648033Atovaquone With Radical ChemorADIotherapy in Locally Advanced NSCLC
NCT05628376TRAcking Thoracic Cancer Evolution Through Therapy (Rx) EVO
NCT00896818Genes and Other Risk Factors for Second Primary Breast Cancer in Women With Breast Cancer and Their Female Family Members and Friends
NCT00002460Adjuvant Hormone Therapy in Treating Women With Operable Breast Cancer
NCT02310997Myloablative Cord Blood Transplant in Haematological Malignancies (MAC UCBT)
NCT00450203Chemotherapy With or Without Bevacizumab or Lapatinib to Treat Operable Oesophagogastric Cancer
NCT01398085IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
NCT02761915A Phase I Trial of Anti-GD2 T-cells (1RG-CART)
NCT00907036Fludarabine Phosphate, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed Hodgkin Lymphoma
NCT03862911Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Oligometastatic (1-3 Metastases) Cancer
NCT06988475DETERMINE Trial Treatment Arm 06: Capmatinib in Adult Patients With Cancers Harbouring MET Dysregulations
NCT01140737A Study of Axitinib in Patients With Advanced Angiosarcoma and Other Soft Tissue Sarcomas
NCT07440290DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.
NCT01460888Radiotherapy & Olaparib in COmbination for Carcinoma of the Oesophagus
NCT04307576A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
NCT00002476Radiation Therapy With or Without Chemotherapy in Treating Patients With Advanced Head and Neck Cancer
NCT05877352Intraoperative Electron Radiotherapy in Rectal Cancer - A Feasibility Trial
NCT01212887Treated Blood Cells, Cyclophosphamide, Fludarabine Phosphate, and Aldesleukin in Treating Patients With Cancer